Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruption.
Erica P CahillKlaira LermaKate A ShawPaul D BlumenthalPublished in: BMJ sexual & reproductive health (2022)
NCT03354117.